Director, Pipeline Strategy and Innovation Excellence - Remote

Job Description Summary

Location: Remote, East Hanover, NJ Preferred

Over the next 4-years, Novartis is expected to launch up to 37 new medications and line ex-tensions and our Novartis Patient Support team is on the forefront of transforming how the industry helps patients get access to treatment. Our ambition is high, but we are proud and not satisfied. If you’d like to be part of our journey, then come join our team!

The Director of Pipeline Strategy and Innovation Excellence is a critical thought leader who will enrich the customer, patient and internal stakeholder experience delivered by Novartis Patient Support (NPS) programs across our portfolio. As NPS continues to develop trans-formative capabilities, this role will be key to unlock efficiencies, embed future forward tech-nology and accelerate the delivery of simple, scalable, consumer experiences. The role re-quires a deft understanding of data-driven perspectives on what current “best practices” look like within Novartis Programs, supplemented with ongoing, strategic review of innovation in the external marketplace.

This individual is responsible for building strategic foresight and an intimate understanding of emerging 3-year needs based on anticipated portfolio evolution. The ideal candidate easily digests clinical trial design and early asset literature to develop an understanding for emerging therapeutic product profile, competitive positioning and alignment to existing NPS product archetypes, identifying gaps in our current capabilities for future development.

The ideal candidate will formalize hypothesis-driven innovation scans from a variety of external sources to drive a cycle of perpetual innovation at every step of the patient journey managed by NPS. The role assumes experience and comfort working closely with external & internal stakeholders across functions in a large pharma environment. Successful candidates will have a strong background in patient services, with high emphasis on identifying innovations that simplify & modernize the experiences delivered via Patient Support Programs. The role builds on the robust voice and strategic ownership of such investments already in place in the US business for Novartis. It comes with high visibility to senior Leadership in the US.

This Director will partner with a team of 2 Associate Directors.

 

Job Description

Your responsibilities will include, but are not limited to:

Pipeline Strategy

Team member will serve as key leader partnering with two Associate Directors on the following:

• Needs Assessment: Reads clinical pipeline to understand emerging needs.  Understands clinical trial design for emerging NPS portfolio, risks, requirements and how they will likely translate into product label. 
• Competitive Positioning: Compares Novartis asset therapeutic profiles to emerging competitive set to assess competitive positioning and payer dynamics.  Evaluates the design on competitive tactics to inform Novartis strategy.
  • Serves as key team member to present recommendations and partner with the disease state team on design and pull through
• Strategic Foresight: Develops 3-year strategic roadmap and benchmarks for patient services capabilities, leveraging design menus to understand where capabilities already exist and where we need to learn more
  • Develops and periodically refines detailed views of the Novartis IM portfolio, mid and long-term pipeline and synthesizes likely scenarios for Patient Services needs and Program footprints for each asset
• Accelerate: Creates accelerator packages to equip and train Disease State Teams and LaunchEx stakeholders as they pick up work on an asset in the T-18 timeframe.  Examines existing offerings within NPS to prioritize areas of capability evolution
• Ecosystem Landscaping: Research available offerings from other ecosystem players (e.g. Payers, Specialty Pharmacies, Health Systems and advocacy) and marries with patient insights to determine optimal design of manufacturer investments
• Disseminate Findings: Partners with Insights, Innovation and Design team members to socialize findings and build the optimal strategy for transition to Launch Excellence and Disease State Teams
  • Continues to partner with NPS franchise teams across the IM portfolio for upcoming new to market launches to refine and crystallize program footprints and required capabilities, enhance enterprise understanding of needs for various drug archetypes (Retail, Specialty, Buy & Bill, Advanced modalities including Radioligand therapy)
• Inform Strategic Decisions: Drives inputs on launch and Program migration roadmaps and sequencing via strategic capability choices, continuously partners with NP